Form 4 Tracker
Thomas Sciascia

Chief Scientific Officer · 1 filing · Latest: Feb 19, 2026

Trevi Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing